CN112111448B - 改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 - Google Patents
改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 Download PDFInfo
- Publication number
- CN112111448B CN112111448B CN202010847844.5A CN202010847844A CN112111448B CN 112111448 B CN112111448 B CN 112111448B CN 202010847844 A CN202010847844 A CN 202010847844A CN 112111448 B CN112111448 B CN 112111448B
- Authority
- CN
- China
- Prior art keywords
- mesenchymal stem
- stem cell
- culture medium
- component
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/80—Neurotransmitters; Neurohormones
- C12N2501/825—Serotonine (5-HT); Melatonine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010847844.5A CN112111448B (zh) | 2020-08-21 | 2020-08-21 | 改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 |
US17/404,826 US20220056415A1 (en) | 2020-08-21 | 2021-08-17 | Modified mesenchymal stem cell culture medium, bone marrow mesenchymal stem cells and culture methods and use thereof |
EP21192325.5A EP3957719A1 (en) | 2020-08-21 | 2021-08-20 | Modified mesenchymal stem cell culture medium, bone marrow mesenchymal stem cells and culture methods and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010847844.5A CN112111448B (zh) | 2020-08-21 | 2020-08-21 | 改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112111448A CN112111448A (zh) | 2020-12-22 |
CN112111448B true CN112111448B (zh) | 2022-06-10 |
Family
ID=73804290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010847844.5A Active CN112111448B (zh) | 2020-08-21 | 2020-08-21 | 改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220056415A1 (zh) |
EP (1) | EP3957719A1 (zh) |
CN (1) | CN112111448B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113186157A (zh) * | 2021-06-08 | 2021-07-30 | 深圳市弘际生物科技有限责任公司 | 一种间充质干细胞在制备用于治疗膀胱过度活动综合症的药物中的应用 |
CN113384658A (zh) * | 2021-07-09 | 2021-09-14 | 杨水祥 | 一种含有干细胞提取液的生发剂及其使用方法 |
CN113455651A (zh) * | 2021-07-09 | 2021-10-01 | 杨水祥 | 一种含有干细胞提取液的代谢和免疫增强及改善亚健康制剂 |
CN114621916A (zh) * | 2022-03-16 | 2022-06-14 | 北京唐颐惠康生物医学技术有限公司 | 抗氧化剂在提高脐带间充质干细胞活力中的应用 |
WO2023189485A1 (ja) * | 2022-03-31 | 2023-10-05 | 株式会社サイト-ファクト | 間葉系幹細胞の品質評価方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014521337A (ja) * | 2011-07-29 | 2014-08-28 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | 幹細胞由来の組織細胞中の代謝成熟 |
EP2614829A1 (en) * | 2012-01-11 | 2013-07-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons |
CN102978156A (zh) * | 2012-11-13 | 2013-03-20 | 湖州市中心医院 | 一种骨髓间充质干细胞的体外扩增纯化培养方法及培养基 |
CN102920735A (zh) * | 2012-11-14 | 2013-02-13 | 青岛奥克生物开发有限公司 | 一种间充质干细胞注射液及其制备方法和在制备治疗糖尿病药物中的应用 |
KR101588394B1 (ko) * | 2013-05-09 | 2016-01-25 | 라정찬 | 줄기세포의 재생능 향상을 위한 배지 조성물 및 이를 이용한 줄기세포의 배양방법 |
EP3578639A4 (en) * | 2017-01-31 | 2020-07-08 | Oriental Yeast Co., Ltd. | MEANS TO ACCELERATE THE GROWTH OF STEM CELLS WITH DIFFERENTIATION POTENTIAL |
FR3065225B1 (fr) * | 2017-04-12 | 2024-04-05 | Patrick Choay Sas | Adjuvants depourvus de cytokines pour milieux de culture cellulaire, notamment pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons |
CN108300690A (zh) * | 2018-02-07 | 2018-07-20 | 北京汇智驰康生物科技有限公司 | 一种脂肪间充质干细胞的分离培养方法和无血清培养基 |
CN108456655A (zh) * | 2018-02-23 | 2018-08-28 | 深圳至博生物科技有限公司 | 间充质干细胞悬浮液及其制备方法与应用 |
DE202018103067U1 (de) * | 2018-05-30 | 2018-06-20 | Caire Medical-Biotechnology International Co. | Zur Vermehrung und Gewinnung mesenchymaler Stammzellen geeignetes serumfreies Zellkulturmedium |
CN110172445A (zh) * | 2019-04-15 | 2019-08-27 | 华南生物医药研究院 | 扩增骨髓间充质干细胞的方法、培养基及应用 |
CN110468099B (zh) * | 2019-07-19 | 2023-08-15 | 海门生原干细胞科技有限公司 | 一种骨髓间充质干细胞培养基及其应用 |
CN111073848B (zh) * | 2020-01-02 | 2023-07-07 | 佛山辅康生物科技有限公司 | 一种卵裂期胚胎培养组合物及卵裂期胚胎培养液 |
CN111281884A (zh) * | 2020-02-11 | 2020-06-16 | 卡替(上海)生物技术股份有限公司 | 应用干细胞疗法减少糖尿病患者胰岛素用量的方法 |
-
2020
- 2020-08-21 CN CN202010847844.5A patent/CN112111448B/zh active Active
-
2021
- 2021-08-17 US US17/404,826 patent/US20220056415A1/en active Pending
- 2021-08-20 EP EP21192325.5A patent/EP3957719A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3957719A1 (en) | 2022-02-23 |
US20220056415A1 (en) | 2022-02-24 |
CN112111448A (zh) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112111448B (zh) | 改良的间充质干细胞培养基、骨髓间充质干细胞及其培养方法和应用 | |
KR100821128B1 (ko) | 지방 조직으로부터 줄기세포를 생성하는 방법 및 시스템 | |
WO2010069204A1 (zh) | 亚全能干细胞、其制备方法及其用途 | |
US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
EP2726603A1 (en) | Brown fat cell compositions and methods | |
KR20120008223A (ko) | 양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법 | |
CN112481202B (zh) | 血小板裂解物无血清分离培养脐带间充质干细胞的方法 | |
CN110938590B (zh) | 一种间充质干细胞无血清培养基及其用途 | |
CN111118046A (zh) | 一种能够调控MSCs成脂肪分化能力的基因及其衍生产品 | |
CN113692282A (zh) | 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途 | |
Deng et al. | Combination of retinoic acid, dimethyl sulfoxide and 5-azacytidine promotes cardiac differentiation of human fetal liver-derived mesenchymal stem cells | |
WO2006134951A1 (ja) | 脂肪由来幹細胞の長期培養増殖法 | |
CN108588017B (zh) | 一种脐带间充质干细胞的扩增方法及其在关节炎上的应用 | |
CN111748522A (zh) | 一种干细胞培养基及其应用 | |
JP6721504B2 (ja) | 多能性幹細胞及び前駆細胞を生産するためのプロセス | |
CN113201491B (zh) | 一种促进干细胞体外增殖和分化的培养方法 | |
Hefei et al. | Morphological characteristics and identification of islet‐like cells derived from rat adipose‐derived stem cells cocultured with pancreas adult stem cells | |
CN112608892B (zh) | 血小板裂解物用于无血清分离和传代培养脐带间充质干细胞的方法 | |
CN114214272A (zh) | 一种诱导脐带间充质干细胞分化心肌细胞的方法、培养基及其应用 | |
CN114507638A (zh) | 一种抑制间充质干细胞衰老的优化培养基及其应用 | |
AU2021222342A1 (en) | Method for treating chronic graft versus host disease | |
CN109749981B (zh) | 人源脂肪干细胞来源的肝细胞样细胞及其制备方法和应用 | |
CN112458047A (zh) | 分离胎盘间充质干细胞的方法和使用的无血清培养基 | |
WO2011134707A1 (en) | Method for modifying the proliferative activity and differentiation capacity of multipotent mesenchymal stromal cells | |
EP4144835A1 (en) | Method for culturing cell population containing cartilage-derived tie2-positive cells, and use of said method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210527 Address after: A2901, building 11, Shenzhen Bay science and technology ecological park, No.16, Keji South Road, high tech community, Yuehai street, Nanshan District, Shenzhen, Guangdong 518000 Applicant after: Shenzhen Hongji Biotechnology Co.,Ltd. Address before: 36d2, 36d2, 36F, Nord financial center, No. 1006, Fuzhong Third Road, Lianhua street, Futian District, Shenzhen City, Guangdong Province Applicant before: Shenzhen Zhongke Guangrui Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230414 Address after: Rehabilitation Industry Incubator 30105, Building D, No. 100 Torch Road, High tech Zone, Qingdao, Shandong Province, 266000 Patentee after: Yuansheng Biotechnology (Qingdao) Co.,Ltd. Address before: A2901, building 11, Shenzhen Bay science and technology ecological park, No.16, Keji South Road, high tech community, Yuehai street, Nanshan District, Shenzhen, Guangdong 518000 Patentee before: Shenzhen Hongji Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |